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Abstract
Purpose: Stroke survivors are at high risk of developing cognitive syndromes, such as delirium and dementia. Accurate
prediction of future cognitive outcomes may aid timely diagnosis, intervention planning, and stratification in clinical trials.
We aimed to identify, describe and appraise existing multivariable prognostic rules for prediction of post-stroke cog-
nitive status.
Method: We systematically searched four electronic databases from inception to November 2019 for publications
describing a method to estimate individual probability of developing a cognitive syndrome following stroke. We
extracted data from selected studies using a pre-specified proforma and applied the Prediction model Risk Of Bias
Assessment Tool (PROBAST) for critical appraisal.
Findings: Of 17,390 titles, we included 10 studies (3143 participants), presenting the development of 11 prognostic
rules – 7 for post-stroke cognitive impairment and 4 for delirium. Most commonly incorporated predictors were:
demographics, imaging findings, stroke type and symptom severity. Among studies assessing predictive discrimination,
the area under the receiver operating characteristic (AUROC) in apparent validation ranged from 0.80 to 0.91. The
overall risk of bias for each study was high. Only one prognostic rule had been externally validated.
Discussion/conclusion: Research into the prognosis of cognitive outcomes following stroke is an expanding field, still
at its early stages. Recommending use of specific prognostic rules is limited by the high risk of bias in all identified studies,
and lack of supporting evidence from external validation. To ensure the quality of future research, investigators should
adhere to current, endorsed best practice guidelines for conduct of prediction model studies.
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Introduction
Stroke survivors are at a high risk of developing cog-
nitive syndromes, which can compromise independence
in daily activities, social participation and quality of
life.1,2 Cognitive problems can be evident at all stages
of the stroke journey, from acute deficits and delirium
in the early days,3 to persisting single and multidomain
impairment,4,5 where for some the latter will eventually
take on the severe, progressive form of post-stroke
dementia.6,7
Change to cognitive function following stroke is a
heterogeneous process, with many factors likely to
affect its course.8,9 Accurate prognosis of cognitive syn-
dromes is, therefore, likely to require the approach
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applied in prediction model studies.10 This entails con-
sidering a range of candidate predictor variables, iden-
tified based on existing evidence, from which those with
an independent association with an outcome are select-
ed. They are then combined to estimate the probability
for an individual to develop that specific outcome,
forming a prognostic rule.
A robust instrument for predicting post-stroke cog-
nitive outcomes may improve risk stratification and
inform provision of appropriate treatments and sup-
port. Many tools for predicting cognitive disorders in
the general community-dwelling and inpatient popula-
tion have been described.11,12 However, stroke cases
arguably require bespoke prognostic rules that take
account of distinctive baseline risk factors, the acute
setting, and the importance of the index stroke and
consequent treatment.
The aim of this review was to identify, describe and
appraise existing prognostic rules for predicting post-
stroke cognitive syndromes. Our assessment of rule
performance and utility considered both the develop-
ment process, and any external validation or impact
studies.
Methods
We completed this review in accordance with the
Checklist for critical Appraisal and data extraction
for systematic Reviews of prediction Modelling
Studies (CHARMS)13 and Preferred Reporting for
Systematic Review and Meta-Analyses (PRISMA)
guidelines.14 The protocol can be accessed through
the PROSPERO International Prospective Register of
Systematic Reviews (registration number:
CRD42020170428). Two researchers (BAD and KM)
independently conducted all tasks involved in study
selection, data extraction, and critical appraisal.
Disagreements were discussed and resolved through
consensus. Where an agreement could not be reached,
a third, senior researcher was consulted (TJQ).
Search strategy and selection criteria
We searched MEDLINE (OVID), EMBASE (OVID),
PsycINFO (EBSCO), and CINAHL (EBSCO) from
inception to November 13, 2019. Our aim was to iden-
tify studies describing the development, validation or
impact of prognostic rules for prediction of post-stroke
cognitive syndromes. Under the term of “post-stroke
cognitive syndromes”, we encapsulated delirium as an
acute (direct) consequence of stroke, and any form of
global cognitive impairment, developed in the short or
longer-term following stroke, including mild cognitive
impairment and dementia.
We developed a search strategy based on validated
search filters, tailored to the specific review question
with support from a Cochrane Information Specialist.
For all databases, the search involved terms relevant
to stroke, cognition and prognosis, combined with
the Boolean operator AND. The search was limited
to human studies published in English. Additional
studies were identified through screening reference
lists of relevant reviews, and backward and forward
citation searches from included publications. The full
search strategy is available in the Supplemental
Material.
The inclusion criteria were intentionally broad. We
screened titles and abstracts using the Rayyan Qatar
Computing Research Institute online application.15
Studies were eligible if they included participants
aged 18 or over, with a clinical diagnosis of stroke.
Relevant outcomes reflected global cognitive status,
determined by the use of brief screening tools, neuro-
psychological batteries, or expert individual or consen-
sus diagnosis, based on recognised medical
classification criteria. Apart from case studies, all
study designs were potentially eligible, provided predic-
tor data related to an earlier time-point than the out-
come. In relation to randomised controlled trials, we
applied additional inclusion criteria for prognostic
models to either have been developed in the control
arm or to include receiving the experimental interven-
tion as a predictor.
We excluded studies that involved participants with
subarachnoid haemorrhage, predicted performance
within one specific cognitive domain only (e.g. lan-
guage), assessed cognitive outcome based on self-
report measures, or were not available as a full
published paper in a peer-reviewed journal. We
applied no limits based on study setting or length of
time from index stroke to outcome assessment. In the
final stage, we excluded prognostic model develop-
ment studies that did not provide a method for esti-
mating individual outcome probability (e.g. using a
mathematical formula, graphical tool or online
calculator).
Data extraction and quality assessment
We used a pre-specified, piloted proforma to extract
data from selected studies, including information on:
study setting, development sample characteristics, pre-
dictor and outcome variables, methods of model deri-
vation and validation, and measures of prediction rule
performance. We distinguished the following levels of
prognostic rule validation, beginning from least strin-
gent: 1) apparent, 2) internal, 3) temporal, and 4) exter-
nal validation.16 Definitions of validation strategies
and a description of considered prognostic rule
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performance measures are presented in the
Supplemental Material.
We assessed risk of bias for each included study
using the Prediction model Risk Of Bias Assessment
Tool (PROBAST).17 The tool comprises four domains:
participants, predictors, outcome and analysis, each
appraised separately and then considered in conjunc-
tion to make an overall judgment on risk of bias (inter-
nal validity). Three study domains (with the exclusion
of analysis) are additionally rated on applicability, i.e.
relevance to the populations and settings targeted by
the review.
Results
Of 17,390 titles, we included 10 studies, presenting the
development of 11 prognostic rules (Figure 1).18–27 In
total, 3143 participants from seven different Asian and
European countries were involved in development of
prognostic models. Predicted post-stroke outcomes
included any form of global cognitive impairment,
dementia, and delirium. Due to differences in clinical
course, considered risk factors, and in turn – related
modelling challenges – we described prognostic rules
for delirium separately. Characteristics of identified
development studies are summarised in Table 1.
Figure 1. Flowchart of study selection and inclusion process.
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Characteristics of included participants are presented
in Supplemental Table 1.
Prognostic rules for cognitive impairment
Overview. Seven studies addressed development of post-
stroke cognitive impairment,18–24 including two focus-
ing specifically on dementia (Table 2).22,24 The
CHANGE18 score was developed to overcome limita-
tions of an earlier prognostic rule – SIGNAL2
21 – and
was derived using the same dataset. All studies explic-
itly stated exclusion of individuals with pre-existing
cognitive impairment, four studies excluded partici-
pants based on severity of specified symptoms,18,19,21,24
and four – based on psychiatric comorbidity.18,19,21,23
One prognostic rule was developed based on Chi-
square Automatic Interaction Detection (CHAID)
algorithm analysis,24 while all other studies employed
logistic regression. On average, the identified prognos-
tic rules included five variables (range: 3–7). Greatest
overlap was observed for demographics and imaging
findings, with both types of variables incorporated
into five prognostic rules (Table 3). Across all studies,
participant outcomes were determined at 3 to
12months post-stroke. Among the five studies that
assessed discrimination, the reported area under the
receiver operating characteristic (AUROC) in apparent
validation ranged from 0.81 (good)23 to 0.91
(excellent).20
Risk of bias and applicability. We rated all studies as high
risk of bias in the domain of analysis (Table 4), with
two reasons applicable to each case – inappropriate
handling of missing data and not accounting for data
complexities (use of analysis methods that do not allow
for inclusion of censored participants). Two studies did
not assess discrimination,22,24 while calibration was not
assessed appropriately19 or at all22–24 in four studies.
Assessment of rule performance was limited to appar-
ent validation in two studies,19,22 while no validation
procedure was reported by Salihovic et al.24 Only
CHANGE18 was externally validated. Given the
broad review question, applicability was overall of
low concern, with one exception in the domain of pre-
dictors. Munsch et al.23 obtained information on stroke
location based on the outcome, using lesion symptom
mapping, rather than prior to outcome assessment.
Prognostic rules for delirium
Overview. Three studies aimed to predict risk of deliri-
um,25–27 producing four prognostic rules (two alterna-
tives in Kostalova et al.25). None of the studies
excluded individuals based on pre-existing cognitive
Table 1. Characteristics of included studies.
Study Country Setting Design Stroke type
Development
sample size, N








Ding 2019 China Neurology department
of university hospital
Prospective cohort Ischaemic 145














Lin 2003 Taiwan Neurology department
of university hospital
Prospective cohort Ischaemic 283





Salihovic 2018 Bosnia and
Herzegovina
Neurology department





Prognostic rules for delirium





Kotfis 2019 (DELIAS) Poland Neurology department
of district general
hospital
Prospective cohort Ischaemic 1001
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impairment, one study excluded subjects with a history
of psychiatric disorder (psychosis).25 All prognostic
models were developed using logistic regression analy-
sis. On average, the prognostic rules included five var-
iables (range: 4–7). Each used demographic
information, and three incorporated stroke type.
When compared to rules for cognitive impairment,
we found inclusion of two types of variables to be
unique – acute medical complications25,27 and labora-
tory markers.25,26 On account of the fluctuating course
of delirium, in all studies the outcome was assessed on
multiple occasions. Kostalova et al.25 and Kotfis
et al.26 conducted assessments daily for up to eight
and six days, respectively, including the day of hospital
admission. Oldenbeuving et al.27 screened for delirium
on two separate days within a seven day period from
admission. Regarding rule performance, out of the two
studies that assessed discrimination in apparent
validation, Oldenbeuving et al.27 reported the higher
estimate (AUROC¼ 0.84).
Risk of bias and applicability. We rated all studies as high
risk of bias in domains of outcome and analysis.
Regarding the former, risk of bias was judged as high
due lack of blinding to predictors, or even use of pre-
dictor knowledge to inform outcome assessment. In
terms of analysis, common concerns related to insuffi-
cient sample size, inappropriate handling of missing
data and/or data complexities, and no evaluation of
rule calibration. Assessment of discrimination was
omitted from the study by Kostalova et al.,25 while
Kotfis et al.26 applied no method to adjust for opti-
mism in estimating the performance of DELIAS.
Among the three studies, the most stringent form of
validation (temporal) was applied by Oldenbeuving
et al.27

















Prognostic rules for cognitive impairment
Chander 2017 (CHANGE)  
Ding 2019   
Gong 2019   
Kandiah 2016 (SIGNAL2)  
Lin 2003     
Munsch 2016   
Salihovic 2018 
Prognostic rules for delirium
Kostalova 2012; Rule 1    
Kostalova 2012; Rule 2    
Kotfis 2019 (DELIAS)    
Oldenbeuving 2014    
Table 4. Assessment of risk of bias.
Study Participants Predictors Outcome Analysis Overall assessment
Prognostic rules for cognitive impairment
Chander 2017 (CHANGE) 2 1 2 2 2
Ding 2019 1 1 ? 2 2
Gong 2019 1 1 1 2 2
Kandiah 2016 (SIGNAL2) 2 1 2 2 2
Lin 2003 1 1 2 2 2
Munsch 2016 1 2 1 2 2
Salihovic 2018 1 1 2 2 2
Prognostic rules for delirium
Kostalova 2012 1 1 2 2 2
Kotfis 2019 (DELIAS) 1 ? 2 2 2
Oldenbeuving 2014 1 2 2 2 2
1 indicates low risk of bias; 2 indicates high risk of bias; ? indicates unclear risk of bias.
24 European Stroke Journal 6(1)
Applicability was of high concern in studies by
Kostalova et al.25 and Oldenbeuving et al.,27 due to
risk of overlap in timing of predictor and outcome
assessments. Regarding the publication by Kotfis
et al.,26 we rated applicability as unclear, as we could
not ascertain whether predictor information was
obtained prior to the outcome.
Discussion
We identified 11 prognostic rules for prediction of
post-stroke cognitive syndromes, three of which had
been published in the last year. However, none of
these rules are ready for routine clinical use, with no
independent external validation, or assessments
describing implementing the prognostic rules in prac-
tice. Research into prognosis of post-stroke cognitive
outcomes is an expanding area, but still at its early
stages, with a primary focus on development of novel
strategies, rather than validation or application.
Clinical implications
Based on our data, preferred prognostic rules for pre-
diction of either post-stroke delirium or cognitive
impairment cannot be recommended. All included
studies had strengths and limitations. The study by
Gong et al.20 was rated to have high risk of bias in
only one domain, and reported the highest discrimina-
tory power in apparent validation (AUROC¼ 0.91).
However, it is important to note the small development
sample size, and that the rule was developed exclusively
for use in haemorrhagic stroke.
Studies by Chander et al. (CHANGE)18 and
Oldenbeuving et al.27 applied the most stringent vali-
dation strategies and produced risk scores that allow
for easy estimation of individual prognosis. Yet, the
same two studies had the highest number of domains
rated as high risk of bias (three out of four) in our
quality assessment. In external validation,
CHANGE18 was shown to have only fair discrimina-
tory power. This measure of predictive ability was
unavailable for any of the other prognostic rules.
A fundamental challenge is that without external
validation studies, the generalisability of developed
prognostic rules cannot be assessed. To choose an opti-
mal prognostic rule, it is also essential to consider the
target population and setting. For example,
CHANGE18 and SIGNAL2
21 were specifically
intended for survivors of non-disabling stroke, and
may not be applicable in an unselected stroke popula-
tion. Generalisability may also me compromised if a
tool relies on predictor information that is not avail-
able in all healthcare systems. An example is use of a
neuroimaging score, which may not be attainable in
resource-poor settings. Ultimately, uptake of prognos-
tic rules in clinical practice is likely to depend on ease of
use, clear implications of the prognostic tool results,
and the economic and opportunity cost of any changes
in workload.
Research implications
Until external validation studies become available, risk
of bias ratings offer some indication of how well a
prognostic rule may perform when applied in a new
population. Common themes from our PROBAST rat-
ings highlight some of the challenges inherent to stroke
prognostic research. Stroke-related impairments limit-
ing completion of certain assessments,28 deaths and
losses to follow-up can all contribute to missing data
and biased study samples. Another challenge relates to
incorporation bias, where the assessment of the out-
come of interest requires knowledge of factors that
inform the prognostic tool. For example, a diagnosis
of delirium according to the Diagnostic and Statistical
Manual of Mental Disorders, 5th edition (DSM-5)29
requires obtaining evidence of a potential cause, such
as infection. Such pitfalls may be impossible to avoid,
yet other identified issues could have been at least par-
tially ameliorated, e.g. enabling inclusion of partici-
pants with missing data by applying imputation
techniques.
Despite these limitations, the reviewed studies form
an important foundation for future research into stroke
and cognition. They identify key predictors for devel-
opment of cognitive disorders, and are necessary for
the next stages of prediction model research – external
validation, updating and impact assessment. All with
the ultimate aim of implementing useful prognostic
rules in routine practice.
Recognition of methodological limitations encoun-
tered in existing publications, and application of the
comprehensive, rigorous and explicit guidance pre-
sented within the recently published PROBAST tool,
can help raise standards in design, conduct and report-
ing of future prediction model studies. The develop-
ment and validation of prognostic tools requires
multiple, large datasets of individual participant data
and prospective follow-up. The stroke cognition com-
munity benefits from collective efforts to bring together
international datasets with a cognitive focus, and these
provide an ideal platform for future prognostic
research.30
Strengths and limitations
This is the first systematic review to focus on prognos-
tic rules for prediction of post-stroke cognitive syn-
dromes – a priority concern for many stroke
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survivors. The opportunity to use the relatively novel
PROBAST tool posed an important advantage to com-
pleting this work. Lack of a consensus approach to risk
of bias assessment has limited previous prognostic
reviews.31 Another strength relates to the search strat-
egy and inclusion criteria being specifically designed to
ensure comprehensiveness.
However, due to limited resources, the search only
focused on studies published in English. Moreover, by
requiring that publications provide a method to estimate
the individual probability of cognitive outcomes, studies
relying on more complex prediction techniques, such as
machine learning, would have been excluded. However,
this was deliberate to ensure the review would be useful
to clinicians and researchers through focusing on meth-
ods which are prepared for immediate application, pro-
vided predictor information is readily available.
Conclusion
Research into prognosis of post-stroke cognitive out-
comes is evolving. At present, any recommendation for
implementing specific prognostic rules seems prema-
ture, due to high risk of bias identified in all considered
studies, lack of evidence from external validation, and
applicability being dependent on the context of use.
Adherence to current, endorsed best practice guidelines
for developing and validating prognostic rules is key to
ensure improvement in the quality of future research
work. External validation studies are particularly
needed for this field to progress to its next stages,
with a view to eventually implement prognostic rules
for post-stroke cognitive outcomes in routine practice.
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